The possibility of approval of the Progensa® PCA3 test here in the USA any time soon appears to have received a setback. According to a media release from DiagnoCure — a Canadian company that developed the test in association with U.S.-based Gen-Probe — the U.S. Food & Drug Administration (FDA) has delayed the scheduled review prostatecancerinfolink.net
You can link to this article on your web site using following code:
Website Code:
Forum Code:
Comments
We're looking for comments that are interesting, substantial or highly amusing. If your comments are excessively self-promotional (use your real name, no keywords please), obnoxious, or even worse, boring, you will be banned from commenting. Your comment must be related to the post. Please do not comment on how great or wonderful the post is. All comments are moderated and, if approved, will display in less than 24 hours.
prostatecancerinfolink.net
